Sagittarius Life Science Cash Flow Reinvestment Rate
Sagittarius Life Science cash flow reinvestment rate. Sagittarius Life Science (3205) has a Cash Flow Reinvestment Rate of 143.42x as of September 2025, reinvesting NT$17.93 Million (capex NT$83.00K plus investments NT$17.84 Million) from operating cash flow of NT$125.00K. Explore Sagittarius Life Science (3205) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sagittarius Life Science (2015–2016)
Cash flow reinvestment rate of Sagittarius Life Science from 2015 to 2016. Historical reinvestment intensity for Sagittarius Life Science across 2 annual periods. Explore 3205 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Sagittarius Life Science Cash Flow Reinvestment Rate by Year (2015–2016)
Sagittarius Life Science cash flow reinvestment rate by year from 2015 to 2016. Year-by-year capital reinvestment analysis for Sagittarius Life Science. For the full cash flow conversion analysis, see cash efficiency ratio of Sagittarius Life Science.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.29x | NT$104.28 Million | NT$360.37 Million | NT$19.76 Million | ▲ +15.2% |
| 2015 | 0.25x | NT$59.76 Million | NT$237.94 Million | NT$2.95 Million | — |